Business UpdateJul 13, 2026, 07:22 AM
Tonix Pharmaceuticals Expands TONMYA Coverage to 9M Medicare Lives
AI Summary
Tonix Pharmaceuticals announced a new agreement with a pharmacy benefit manager to provide coverage for TONMYA to approximately 9 million Medicare Part D beneficiaries, effective January 1, 2027. This expands TONMYA's total expected coverage to 145 million individuals, or 46% of all covered lives in the U.S., by early 2027. Following these coverage milestones, Tonix is expanding its sales force by 50 new representatives, aiming for a total of 150 by mid-third quarter 2026.
Key Highlights
- Tonix Pharmaceuticals secured an agreement with a PBM for TONMYA coverage for Medicare Part D beneficiaries.
- The agreement adds approximately 9 million Medicare lives, effective January 1, 2027.
- Total TONMYA coverage is expected to reach 145 million lives (46% of US covered lives) by January 1, 2027.
- TONMYA is currently covered by Medicaid in most states, representing 73 million beneficiaries.
- The company plans to expand its sales force by 50 new representatives by mid-Q3 2026, bringing the total to 150.
Price Impact
More from TNXP